Pre-market hot trades in US stocks: Linkhome up 7.45% in pre-market; SMX Security Matters down 4.12% in pre-market

Pre-market Hot Trades in US Stocks Linkhome, up 7.45% in pre-market trading, has no significant news recently. Trading is active with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. SMX down 4.12% in pre-market trading. Based on recent key news: On January 26, SMX announced the expansion of its textile labeling platform to the US cotton market, aiming to enhance brand and supply chain integrity and strengthen the competitiveness of US cotton in the global market. This project may increase the market value of US cotton, but failed to boost the stock price in the short term. On January 26, SMX issued a statement reminding investors to be cautious with forward-looking statements and emphasized that the company has no obligation to update these statements. This uncertainty may lead to a lack of investor confidence, affecting stock performance. On January 27, SMX faces risks from suppliers and manufacturers failing to fulfill obligations in a timely manner, as well as challenges in intellectual property protection. These risk factors may negatively impact the company's business, leading to a decline in stock price. The textile industry is facing supply chain challenges. Top Gainers in Pre-market Trading of US Stocks FAT Brands up 350% in pre-market trading. Based on recent key news: On January 27, FAT Brands announced it is seeking bankruptcy protection in Texas to enhance its capital structure. Nevertheless, its brands such as Fatburger and Johnny Rockets will continue normal operations during the bankruptcy process. This news has boosted market confidence in the company's future, driving a significant rise in stock price. Source: Reuters On January 26, FAT Brands appointed Patrick Bartels and Neal Goldman as independent directors and established a special committee to oversee restructuring matters. This move is seen as a sign of the company's proactive response to financial difficulties, further boosting investor confidence. Source: SEC announcement On January 28, the lawsuit against FAT Brands' CEO for alleged fraud has been dismissed, eliminating legal risks for the company's management and improving market expectations for the company. Source: FOX Business The restaurant industry is facing trends of restructuring and consolidation. TechCreate up 131.47% in pre-market trading. Based on recent key news: On January 30, TechCreate's stock price soared 889% on Thursday, with company management stating there is no undisclosed material information to explain this trading activity. This news led to the stock price continuing to rise over 100% in pre-market trading on Friday. Trading volume reached $280 million, 24 times the average trading volume over the past 20 trading days. Source: Bloomberg On January 30, TechCreate responded to inquiries from NYSE American, confirming there is no undisclosed material non-public information to explain the recent trading activity. Source: TechCreate Group Ltd On January 30th, TechCreate's market capitalization reached $1.76 billion, with its stock price rising 944.26% over the past five days, indicating a strong upward trend. Source: Benzinga Technology stocks have performed strongly recently, and market sentiment is optimistic. VivoSim Labs pre-market rose 90.59%. Based on recent news, On January 29th, VivoSim Labs made a significant announcement, stating that its latest biorealistic simulation technology has made breakthrough progress. This news triggered a strong market reaction, driving the stock price significantly higher. On January 28th, the company also announced a strategic cooperation agreement with a large pharmaceutical company, further enhancing market confidence in its future growth. On January 27th, analysts generally upgraded their ratings for VivoSim Labs, expecting that its new technology will significantly enhance the company's profitability, further driving up the stock price. The biotechnology industry has performed strongly recently, with significant capital inflows